Showing 1 to 2 of 2 results


Optiscan's Gen2 Endomicroscope Launches Pre-Clinical Trial in Germany
Optiscan Imaging, an ASX-listed medtech company, launched a pre-clinical study in Germany for its second-generation flexible endomicroscope, aiming to improve gastrointestinal disease diagnosis and treatment using real-time cellular-level imaging; this collaboration with the University Medical Cente...
Optiscan's Gen2 Endomicroscope Launches Pre-Clinical Trial in Germany
Optiscan Imaging, an ASX-listed medtech company, launched a pre-clinical study in Germany for its second-generation flexible endomicroscope, aiming to improve gastrointestinal disease diagnosis and treatment using real-time cellular-level imaging; this collaboration with the University Medical Cente...
Progress
40% Bias Score

Rising Early-Onset Cancers: A Global Health Concern
A 38-year-old Brazilian woman, Luisa Toscano, was unexpectedly diagnosed with stage three breast cancer in March 2024, despite a healthy lifestyle and no family history, highlighting a global surge in early-onset cancers among young adults, attributed to a combination of factors including diet, life...

Rising Early-Onset Cancers: A Global Health Concern
A 38-year-old Brazilian woman, Luisa Toscano, was unexpectedly diagnosed with stage three breast cancer in March 2024, despite a healthy lifestyle and no family history, highlighting a global surge in early-onset cancers among young adults, attributed to a combination of factors including diet, life...
Progress
36% Bias Score
Showing 1 to 2 of 2 results